Nepedia
Back to Discover
Advanced Reader
🧬

Epstein–Barr virus

life science Maturity 11-13 death dying Next article →

This article covers sensitive topics: death_dying. Parents can manage visibility in Parental Controls.

The Epstein–Barr virus, or EBV, is a member of the herpes family. Scientists also identify it as human herpesvirus 4 (HHV-4). It is a double-stranded DNA virus, meaning its genetic instructions are held in two strands. EBV is one of the most common viruses found in humans. It is also famous in science as the first identified oncogenic virus. An oncogenic virus is a germ that has the ability to cause cancer.

Viral Tegument
Viral Tegument

To understand how EBV works, we must look at its structure. The virus is between 122 and 180 nanometers in diameter. At its center is a double helix of DNA containing about 172,000 base pairs. This DNA encodes 85 different genes. The DNA is wrapped in a protein shell called a nucleocapsid. Surrounding that is a layer of protein known as the tegument. Finally, an outer envelope made of lipids and glycoproteins protects the virus. These surface proteins are essential for the virus to infect a host cell.

EBV uses different methods to enter different types of cells. This specific targeting is called viral tropism. To enter B cells, which are part of the immune system, the virus uses a protein called gp350. This protein binds to a cellular receptor called CD21. Another protein, gp42, then helps the viral envelope fuse with the cell membrane. To enter epithelial cells, the virus uses different tools. The protein BMRF-2 interacts with cellular β1 integrins. Then, the protein gH/gL interacts with αvβ6/αvβ8 integrins to trigger fusion.

EBV infection cycle in healthy humans
EBV infection cycle in healthy humans

Once inside a cell, the virus follows one of two main paths. The first is the lytic cycle, which is a productive infection. In this cycle, the virus makes many new copies of itself. The viral genome must become linear to do this. The virus uses its own enzyme, called DNA polymerase, to copy its DNA. This process happens in three stages: immediate-early, early, and late. Immediate-early genes act as activators for the later stages. Early genes help with replication and metabolism. Late genes produce structural proteins, such as the VCA that forms the viral capsid.

The second path is called latency. During latency, the virus does not produce new infectious particles. Instead, the viral DNA becomes a small circle called an episome. This circle sits in the cell nucleus. Unlike the lytic cycle, the virus uses the host cell's own DNA polymerase to copy itself. The virus stays quiet by using epigenetic changes, like DNA methylation, to suppress most of its genes. In B cells, the virus can follow three different latency programs: Latency I, II, or III. These programs determine which specific viral proteins and RNAs are produced.

EBV infection cycle in healthy humans
EBV infection cycle in healthy humans

EBV infection can change how B cells behave. It can lead to the "immortalization" of these cells. This means the virus causes the B cells to divide indefinitely. Normally, cells have a limited lifespan and eventually die. However, EBV proteins like EBNA-2, EBNA-3C, and LMP-1 allow these cells to keep growing. This ability to persist is why the virus can stay in a person for their entire life. Most people become infected and then gain adaptive immunity. In the United States, about 90% of adults show evidence of a previous infection.

While many people have no symptoms, EBV is linked to many serious conditions. It is the cause of 90% of infectious mononucleosis cases. This illness causes fever, sore throat, and extreme fatigue. EBV is also linked to several cancers, such as Burkitt lymphoma and Hodgkin's lymphoma. It can also cause gastric cancer and nasopharyngeal carcinoma. Globally, about 200,000 cancer cases each year are thought to be caused by EBV.

EBV-cycle-in-immunodeficiency
EBV-cycle-in-immunodeficiency

Recent research has also connected EBV to other major health issues. A 2022 study of 10 million US military members suggested EBV is a leading cause of multiple sclerosis (MS). The study suggested a recent infection could increase the risk of developing MS. The virus is also associated with autoimmune diseases like lupus and rheumatoid arthritis. It can even cause childhood disorders like Alice in Wonderland syndrome. Scientists are still testing various vaccine formulations, but none have been approved yet.

EBV-cycle-in-immunodeficiency
EBV-cycle-in-immunodeficiency
690 words

Where will your curiosity go next?

Keep exploring at your chosen reading level.

🖼️ Images & Media (3)
File:Viral Tegument.svg
Viral Tegument.svg
File:EBV infection cycle in healthy humans.png
EBV infection cycle in healthy humans.png
File:EBV-cycle-in-immunodeficiency.jpg
EBV-cycle-in-immunodeficiency.jpg
More to explore

What is Nepedia?

A free, ad-free encyclopedia for children. Every article is written at five reading levels, so the same page works for a five-year-old and a fifteen-year-old — use the level switcher above to see this one change. No account needed to read.